B. Stein

发表

The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells

H. Goossens, Z. Berneman, M. Peeters, 2016, Oncotarget.

Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions

C. Figdor, Z. Berneman, G. Adema, 2015, Cancer Immunology, Immunotherapy.

Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia.

H. Goossens, G. Juliusson, K. Ladell, 2017, Blood.

Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial.

Z. Berneman, G. Nijs, V. V. Van Tendeloo, 2009, Cytotherapy.

Generation and Cryopreservation of Clinical Grade Wilms' Tumor 1 mRNA-Loaded Dendritic Cell Vaccines for Cancer Immunotherapy.

Z. Berneman, G. Nijs, E. Smits, 2016, Methods in molecular biology.

Induction of Cytomegalovirus-Specific T Cell Responses in Healthy Volunteers and Allogeneic Stem Cell Recipients Using Vaccination With Messenger RNA–Transfected Dendritic Cells

H. Goossens, P. van Damme, Z. Berneman, 2014, Transplantation.

Except for C-C chemokine receptor 7 expression, monocyte-derived dendritic cells from patients with multiple sclerosis are functionally comparable to those of healthy controls.

H. Goossens, G. Nagels, P. Cras, 2014, Cytotherapy.

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination

H. Goossens, K. Ladell, E. Gostick, 2010, Proceedings of the National Academy of Sciences.

Multiple sclerosis (PP-038)

D. Arnold, F. Najafi, A. Bar-Or, 2010 .

Prevention Of Relapse In Acute Myeloid Leukemia By Dendritic Cell Vaccination: Report on a Phase II Study With 29 Patients

K. Vermeulen, Z. Berneman, G. Nijs, 2013 .

Dendritic cell vaccination in malignant pleural mesothelioma: A phase I/II study.

Z. Berneman, G. Nijs, E. Smits, 2014 .

Engineering monocyte-derived dendritic cells to secrete interferon- enhances their ability to promote adaptive and innate anti-tumor immune effector functions Reference:

E. Smits, E. Lion, I. J. M. Vries, 2015 .

Efficient mRNA electroporation of peripheral blood mononuclear cells to detect memory T cell responses for immunomonitoring purposes.

Z. Berneman, N. Cools, A. V. Velde, 2010, Journal of immunological methods.

Generation and Cryopreservation of Clinical Grade Wilms' Tumor 1 mRNA-Loaded Dendritic Cell Vaccines for Cancer Immunotherapy.

Z. Berneman, G. Nijs, E. Smits, 2016, Methods in molecular biology.

Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia.

H. Goossens, G. Juliusson, K. Ladell, 2017, Blood.